Literature DB >> 14999391

[Autoreactive urticaria and autoimmune urticaria].

M Maurer1, M Metz, M Magerl, F Siebenhaar, P Staubach.   

Abstract

Symptoms in patients with autoreactive urticaria (ArU), a sub-form of chronic urticaria (CU), are caused by circulating histamine-releasing signals. ArU patients are readily identified by the autologous serum skin test, in which they exhibit inflammatory reactions to their serum after intracutaneous injection. CU patients who also exhibit functional autoantibodies against IgE and/or its high affinity receptor Fc(epsilon)RI are thought to suffer from autoimmune urticaria (Aiu). ArU and AiU are pathogenetically and clinically different from other sub-forms of CU.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 14999391     DOI： 10.1007/s00105-004-0692-9

Source DB:  PubMed          Journal:  Hautarzt        ISSN： 0017-8470            Impact factor:   0.751


  28 in total

1.  Immune profiles of patients with chronic idiopathic urticaria.

Authors:  Stefania Piconi; Daria Trabattoni; Enrico Iemoli; Maria Luisa Fusi; Maria Luisa Villa; Francesco Milazzo; Mario Clerici
Journal:  Int Arch Allergy Immunol       Date:  2002-05       Impact factor: 2.749

2.  Comparison of serum histamine-releasing activity and clinical manifestations in chronic idiopathic urticaria.

Authors:  T Tanus; P C Atkins; B Zweiman
Journal:  Clin Diagn Lab Immunol       Date:  1996-01

3.  Serum IgG autoantibodies directed against the alpha chain of Fc epsilon RI: a selective marker and pathogenetic factor for a distinct subset of chronic urticaria patients?

Authors:  E Fiebiger; D Maurer; H Holub; B Reininger; G Hartmann; M Woisetschläger; J P Kinet; G Stingl
Journal:  J Clin Invest       Date:  1995-12       Impact factor: 14.808

4.  Reactivity to autologous serum skin test and clinical features in chronic idiopathic urticaria.

Authors:  E Nettis; P Dambra; L D'Oronzio; E Cavallo; M P Loria; M Fanelli; A Ferrannini; A Tursi
Journal:  Clin Exp Dermatol       Date:  2002-01       Impact factor: 3.470

5.  Chronic idiopathic urticaria: comparison of the clinical features of patients with and without anti-FcepsilonRI or anti-IgE autoantibodies.

Authors:  R A Sabroe; P T Seed; D M Francis; R M Barr; A K Black; M W Greaves
Journal:  J Am Acad Dermatol       Date:  1999-03       Impact factor: 11.527

6.  Anti-FcepsilonRIalpha autoantibodies in autoimmune-mediated disorders. Identification of a structure-function relationship.

Authors:  E Fiebiger; F Hammerschmid; G Stingl; D Maurer
Journal:  J Clin Invest       Date:  1998-01-01       Impact factor: 14.808

7.  Assessment of autoimmunity in patients with chronic urticaria.

Authors:  L J Tong; G Balakrishnan; J P Kochan; J P Kinét; A P Kaplan
Journal:  J Allergy Clin Immunol       Date:  1997-04       Impact factor: 10.793

8.  Classification of anti-FcepsilonRI and anti-IgE autoantibodies in chronic idiopathic urticaria and correlation with disease severity.

Authors:  Ruth A Sabroe; Edda Fiebiger; David M Francis; Dieter Maurer; Paul T Seed; Clive E h Grattan; Anne Kobza Black; Georg Stingl; Malcolm W Greaves; Robert M Barr
Journal:  J Allergy Clin Immunol       Date:  2002-09       Impact factor: 10.793

9.  Anti-Fc(episilon)RI auto antibodies and basophil histamine releasability in chronic idiopathic urticaria.

Authors:  R A Sabroe; D M Francis; R M Barr; A K Black; M W Greaves
Journal:  J Allergy Clin Immunol       Date:  1998-10       Impact factor: 10.793

10.  Correlation between T-cell and mast cell activity in patients with chronic urticaria.

Authors:  Bernadett Hidvégi; Eszter Nagy; Teréz Szabó; Erzsébet Temesvári; Márta Marschalkó; Sarolta Kárpáti; Attila Horváth; Péter Gergely
Journal:  Int Arch Allergy Immunol       Date:  2003-10       Impact factor: 2.749
View more
  9 in total

Review 1.  [Chronic spontaneous urticaria: An autoimmune disease?].

Authors:  M Abajian; M Maurer; N Schoepke
Journal:  Hautarzt       Date:  2013-09       Impact factor: 0.751

Review 2.  [Urticaria. "From bench to bedside"].

Authors:  M Magerl; M Maurer
Journal:  Hautarzt       Date:  2007-04       Impact factor: 0.751

Review 3.  [Angioedema prophylaxis].

Authors:  V Zampeli; M Magerl
Journal:  Hautarzt       Date:  2019-02       Impact factor: 0.751

4.  Urticaria: its history-based diagnosis and etiologically oriented treatment.

Authors:  Marcus Maurer; Jürgen Grabbe
Journal:  Dtsch Arztebl Int       Date:  2008-06-20       Impact factor: 5.594

5.  [Hypocomplementemic urticarial vasculitis syndrome. Successful therapy with intravenous immunoglobulins].

Authors:  P Staubach-Renz; E von Stebut; W Bräuninger; M Maurer; K Steinbrink
Journal:  Hautarzt       Date:  2007-08       Impact factor: 0.751

6.  Recurrent facial urticaria following herpes simplex labialis.

Authors:  Vijay Zawar; Kiran Godse
Journal:  Indian J Dermatol       Date:  2012-03       Impact factor: 1.494

7.  Autologous Serum and Plasma Skin Tests in Chronic Spontaneous Urticaria: A Reappraisal.

Authors:  Muthu Sendhil Kumaran; Sonia Mangal; Tarun Narang; Davinder Parsad
Journal:  Indian Dermatol Online J       Date:  2017 Mar-Apr

Review 8.  Immunoglobulin E-Mediated Autoimmunity.

Authors:  Marcus Maurer; Sabine Altrichter; Oliver Schmetzer; Jörg Scheffel; Martin K Church; Martin Metz
Journal:  Front Immunol       Date:  2018-04-09       Impact factor: 7.561

9.  Diagnosis of urticaria.

Authors:  Nicole Schoepke; Georgios Doumoulakis; Marcus Maurer
Journal:  Indian J Dermatol       Date:  2013-05       Impact factor: 1.494
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.